Regulation of β-catenin stabilization in human platelets
- PMID: 23402908
- DOI: 10.1016/j.biochi.2013.01.021
Regulation of β-catenin stabilization in human platelets
Erratum in
-
Corrigendum to "Regulation of β-catenin stabilization in human platelets" [Biochimie 95 (6) (2013) 1252-1257].Biochimie. 2019 Jul;162:239. doi: 10.1016/j.biochi.2019.02.001. Epub 2019 Feb 18. Biochimie. 2019. PMID: 30792097 No abstract available.
Abstract
The Wnt/β-catenin pathway controls developmental processes and homeostasis; however, abnormal activation of this pathway has been linked to several human diseases. Recent reports have demonstrated regulation of platelet function by canonical and non-canonical Wnt signalling. Platelet aggregation plays a crucial role in haemostasis and thrombosis. Here we report for the first time that, induction of sustained aggregation of platelets by a strong agonist in the presence of calcium was associated with nearly complete proteolysis of β-catenin, which was abrogated upon depletion of calcium from platelet suspension. β-catenin cleavage was disallowed in absence of aggregation, thus implicating integrin αIIbβ3 engagement in β-catenin proteolysis. Degradation of β-catenin was blocked partially by inhibitors of either proteasome or calpain and completely when cells were exposed to both the inhibitors. Protein kinase C inhibition, too, abolished β-catenin degradation. Thus activities of proteasome, calpain and protein kinase C regulate stabilization of β-catenin in aggregated human platelets.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
